PD-L1 Expression and Tumor-infiltrating Lymphocytes in Breast Cancer: Clinicopathological Analysis in Women Younger than 40 Years Old
Zoi Evangelou(University Hospital of Ioannina), Anna Batistatou(University of Ioannina)
Cited by 30
Related Papers
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer
|Annals of Oncology|2023|298